Biography:
Sara Maria Majernikova earned a BSc in Biomedical Sciences (specialising in Drug Mechanisms) from University College London and is currently pursuing an MSc in Experimental and Translational Therapeutics at the University of Oxford. Her research interests include innovative drug design, particularly targeting areas such as inflammatory processes, neurodegenerative disorders, chronic diseases, and immunotherapy
Title : Novel anaemia therapy in chronic kidney disease: Expectations and myths of adverse drug reactions